<- Go Home

Nanosonics Limited

Nanosonics Limited operates as an infection prevention company globally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform. The company was incorporated in 2000 and is headquartered in Macquarie Park, Australia.

Market Cap

AUD 1.2B

Volume

1.0M

Cash and Equivalents

AUD 144.5M

EBITDA

AUD 17.1M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

AUD 142.4M

Profit Margin

77.42%

52 Week High

AUD 5.18

52 Week Low

AUD 2.67

Dividend

N/A

Price / Book Value

6.26

Price / Earnings

72.57

Price / Tangible Book Value

6.26

Enterprise Value

AUD 1.0B

Enterprise Value / EBITDA

51.30

Operating Income

AUD 12.5M

Return on Equity

9.09%

Return on Assets

3.25

Cash and Short Term Investments

AUD 144.5M

Debt

AUD 9.2M

Equity

AUD 189.0M

Revenue

AUD 184.0M

Unlevered FCF

AUD 25.5M

Sector

Health Care Equipment and Supplies

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches